Poland's Health Minister to Review EU E-Cigarette Regulations During Council Presidency

Dec.04.2024

Poland's Health Minister has announced plans to review EU regulations on tobacco products and e-cigarettes during its presidency of the EU Council. The move aims to address the growing trend of smoking among young people and ensure stronger regulatory measures to curb tobacco and vaping habits among youth.

According to Portal Spozywczy reported on December 3rd, Polish Minister of Health Izabela Leszczyna stated that during Poland's presidency of the European Council, the country will prioritize three areas in the health sector: digitalization, children's mental health, and disease prevention. Leszczyna announced that Poland will review EU laws on tobacco products and e-cigarettes.

Poland will take over the role of President of the European Council from Hungary starting on January 1, 2025. At that time, senior officials from the Polish government will chair meetings of the European Council.

The Polish Ministry of Health has conveyed the minister's viewpoint through social media platforms. She hopes that Poland's term as President of the European Council will initiate a legislative review of EU tobacco products, nicotine products, and e-cigarettes, including those without nicotine. She emphasized that these nicotine-free products have formed a serious smoking habit among young people.

One of our most important common tasks is to help the young generation in Europe break free from tobacco, nicotine, and other addictive substances. In Poland, the law bans smoking in specific public places, which also applies to e-cigarettes and new tobacco products.

On Tuesday, the European Council approved a new proposal on smoke-free environments, which includes new types of tobacco products such as e-cigarettes and heated tobacco products. (Read more: "EU Council Approves Proposal to Expand Smoke-Free Zones, Including E-Cigarettes and HTPs" )

References:

[1] Leszczyna zapowiada przegląd unijnego prawa w sprawie e-papierosów

Also Read:

[1] Poland Strengthens Vape Regulations, Delays Sales Ban to Minors Until 2025

[2] Polish Health Minister Proposes Ban on Synthetic Nicotine Pouches

[3] Poland Raises Vape Tax to $0.40 Per Milliliter Under New Amendment

[4] Poland youth study shows 80% e-cigarette usage rate, flavors cited as main driver

[5] Poland moves to ban disposable and flavoured e-cigarettes amid rising use of new tobacco products

[6] Strong Discontent towards Polish Tobacco Tax Amendment by IEVA

[7] Poland to Consider Law Banning Sale of E-Cigarettes to Minors

[8] Poland's Finance Ministry proposes amendments to consumption tax law

[9] Poland Plans to Increase Tax on E-Cigarette Liquid: Implications Revealed

#Europe #Poland #Legislation #Tobacco products

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

ZYN’s Trademark Dilemma in China | Legal Opinion Submitted to 2Firsts

ZYN faces trademark revocation and enforcement challenges in China. In this legal commentary submitted to 2Firsts, the author examines regulatory gaps, enforcement hurdles, and the high legal risks surrounding nicotine pouch trademarks.

Oct.14

Ohio Appeals Court Upholds Dismissal of Lawsuit Against E-Cigarette Retailer, Deepening State-Federal Regulatory Dispute

Ohio Appeals Court Rejects State Attorney General's Lawsuit Against E-Cigarette Retailer, Emphasizing FDA Regulatory Authority.

Oct.15 by 2FIRSTS.ai

CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches

CSUR—the Research Institute Supporting Juul and NJOY’s successful PMTAs—assessed FDA’s pilot for nicotine pouches. The program expedites premarket review by deferring behavioral data to post-market reporting. CSUR says this could speed authorizations, but manufacturers must still produce behavioral and real-world evidence after a Marketing Granted Order to maintain compliance with public-health standards.